ICAM1 and neoplasm: To test this, we introduced T cells to the SLB system, which we adapted to function as a minimal system for IS formation, by adding ICAM1 at 200 molecules/μm2 and mimicking the Her2High and Her2Low expression levels on tumor cells (Fig. 4A).